ContentsSynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferencesView all Images (3)
Subacute sclerosing panencephalitis
Print
Other Resources UpToDate PubMed

Subacute sclerosing panencephalitis

Print Images (3)
Contributors: Andrea Wasilewski MD, Jamie Adams MD, Richard L. Barbano MD, PhD
Other Resources UpToDate PubMed

Synopsis

Subacute sclerosing panencephalitis (SSPE) is a progressive neuropsychiatric disorder occurring after natural infection with measles virus. There is typically a history of measles infection at an early age followed by an asymptomatic period, with onset of symptoms starting 7-10 years after primary measles infection. The pathogenesis is unknown but is thought to be related to infection with a variant of measles virus.

The disorder is characterized by development of personality and behavioral changes, progressive cognitive decline, and dementia with seizures, myoclonus, spasticity, ataxia, and vision loss. The final stages of the disease progress to flaccidity, decorticate rigidity, autonomic dysfunction, and eventual coma and death. Disease course is typically progressive but can fluctuate, with some patients having relapsing and remitting symptoms. Patients have elevated antimeasles antibody concentrations in serum and cerebral spinal fluid. Prognosis is poor, and death usually occurs within 3 years of symptom onset.

Codes

ICD10CM:
A81.1 – Subacute sclerosing panencephalitis

SNOMEDCT:
192685000 – Subacute sclerosing panencephalitis

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed: 06/20/2019
Last Updated: 06/21/2019
Copyright © 2020 VisualDx®. All rights reserved.
Subacute sclerosing panencephalitis
Print 3 Images
View all Images (3)
(with subscription)
Subacute sclerosing panencephalitis (Early Stage) : Personality changes, Cognitive decline
Copyright © 2020 VisualDx®. All rights reserved.